European Commission authorises Apretude (cabotegravir long-acting and tablets) for HIV prevention – Viiv HealthCare
GSK plc announced that ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders announced that the European Commission has authorised… read more.